1. Home
  2. VCEL vs HBI Comparison

VCEL vs HBI Comparison

Compare VCEL & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • HBI
  • Stock Information
  • Founded
  • VCEL 1989
  • HBI 1901
  • Country
  • VCEL United States
  • HBI United States
  • Employees
  • VCEL N/A
  • HBI N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • HBI Clothing/Shoe/Accessory Stores
  • Sector
  • VCEL Health Care
  • HBI Consumer Discretionary
  • Exchange
  • VCEL Nasdaq
  • HBI Nasdaq
  • Market Cap
  • VCEL 2.0B
  • HBI 2.3B
  • IPO Year
  • VCEL 1997
  • HBI 2006
  • Fundamental
  • Price
  • VCEL $40.79
  • HBI $6.63
  • Analyst Decision
  • VCEL Strong Buy
  • HBI Hold
  • Analyst Count
  • VCEL 6
  • HBI 5
  • Target Price
  • VCEL $60.40
  • HBI $6.60
  • AVG Volume (30 Days)
  • VCEL 694.4K
  • HBI 7.6M
  • Earning Date
  • VCEL 11-06-2025
  • HBI 11-06-2025
  • Dividend Yield
  • VCEL N/A
  • HBI N/A
  • EPS Growth
  • VCEL 236.54
  • HBI N/A
  • EPS
  • VCEL 0.25
  • HBI 0.93
  • Revenue
  • VCEL $258,716,999.00
  • HBI $3,531,625,000.00
  • Revenue This Year
  • VCEL $18.35
  • HBI $1.61
  • Revenue Next Year
  • VCEL $22.26
  • HBI N/A
  • P/E Ratio
  • VCEL $164.69
  • HBI $7.12
  • Revenue Growth
  • VCEL 14.05
  • HBI 4.55
  • 52 Week Low
  • VCEL $29.24
  • HBI $3.96
  • 52 Week High
  • VCEL $63.00
  • HBI $9.10
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 58.46
  • HBI 52.46
  • Support Level
  • VCEL $37.51
  • HBI $6.42
  • Resistance Level
  • VCEL $41.66
  • HBI $6.68
  • Average True Range (ATR)
  • VCEL 1.88
  • HBI 0.17
  • MACD
  • VCEL 0.04
  • HBI 0.01
  • Stochastic Oscillator
  • VCEL 58.37
  • HBI 80.25

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About HBI Hanesbrands Inc.

Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated, as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina. Hanesbrands has agreed to be acquired by Canadian rival Gildan.

Share on Social Networks: